<!DOCTYPE html><html><head><title>Help for package UnifiedDoseFinding</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {UnifiedDoseFinding}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#get_oc_gBOIN_continuous'>
<p>Generate operating characteristics for finding the maximum tolerated dose (MTD) using gBOIN design</p></a></li>
<li><a href='#get_oc_gBOIN_TB'>
<p>Generate operating characteristics for finding the maximum tolerated dose (MTD) defined by Toxicity Burden (TB) Score  using gBOIN design</p></a></li>
<li><a href='#get_oc_Ivanova_binary'>
<p>Generate operating characteristics for finding the maximum tolerated dose (MTD) of binary endpoint using design by Ivanova et al (2009)</p></a></li>
<li><a href='#get_oc_Ivanova_continuous'>
<p>Generate operating characteristics for finding the maximum tolerated dose (MTD) of continuous endpoint using design by Ivanova et al (2009)</p></a></li>
<li><a href='#get_oc_QuasiBOIN'>
<p>Generate operating characteristics for finding the maximum tolerated dose (MTD) defined by Equivalent Score (ET) using Quasi-CRM design using gBOIN</p></a></li>
<li><a href='#get_oc_RQ_CRM'>
<p>Generate operating characteristics for finding the maximum tolerated dose (MTD) defined by Equivalent Score (ET) using Quasi-CRM design</p></a></li>
<li><a href='#next_gBOIN_continuous'>
<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find a maximum tolerated dose (MTD) using gBOIN design</p></a></li>
<li><a href='#next_gBOIN_TB'>
<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find a maximum tolerated dose (MTD) defined by Toxicity Burden (TB) Score  using gBOIN design</p></a></li>
<li><a href='#next_Ivanova_binary'>
<p>Determine the dose for the next cohort of new patients of binary endpoint using design by Ivanova et al (2009)</p></a></li>
<li><a href='#next_Ivanova_continuous'>
<p>Determine the dose for the next cohort of new patients using Inanova design</p></a></li>
<li><a href='#next_QuasiBOIN'>
<p>Determine the dose for the next cohort of new patients based on equivalent score (ET)-defined target using gBOIN design</p></a></li>
<li><a href='#next_RQ_CRM'>
<p>Determine the dose for the next cohort of new patients using Quasi-CRM design</p></a></li>
<li><a href='#select_mtd_gBOIN_continuous'>
<p>Select the maximum tolerated dose (MTD) for single agent trials using gBOIN design</p></a></li>
<li><a href='#select_mtd_gBOIN_TB'>
<p>Select the maximum tolerated dose (MTD) defined by Toxicity Burden (TB) Score for single agent trials using gBOIN design</p></a></li>
<li><a href='#select_mtd_Ivanova_binary'>
<p>Select the maximum tolerated dose (MTD) of binary endpoint for single agent trials using design by Ivanova et al (2009)</p></a></li>
<li><a href='#select_mtd_Ivanova_continuous'>
<p>Select the maximum tolerated dose (MTD) for single agent trials of continuous endpoint using design by Ivanova et al (2009)</p></a></li>
<li><a href='#select_mtd_QuasiBOIN'>
<p>Select the maximum tolerated dose (MTD)-defined by equivalent score (ET) using gBOIN design</p></a></li>
<li><a href='#select_mtd_RQ_CRM'>
<p>Select the maximum tolerated dose (MTD) using Quasi-CRM design</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Dose-Finding Methods for Non-Binary Outcomes</td>
</tr>
<tr>
<td>Version:</td>
<td>0.1.10</td>
</tr>
<tr>
<td>Author:</td>
<td>Chia-Wei Hsu, Haitao Pan, Rongji Mu</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Chia-Wei Hsu &lt;Chia-Wei.Hsu@stjude.org&gt;</td>
</tr>
<tr>
<td>Description:</td>
<td>In many phase I trials, the design goal is to find the dose associated with a certain target toxicity rate. In some trials, the goal can be to find the dose with a certain weighted sum of rates of various toxicity grades. For others, the goal is to find the dose with a certain mean value of a continuous response. This package provides the setup and calculations needed to run a dose-finding trial with non-binary endpoints and performs simulations to assess designâ€™s operating characteristics under various scenarios. Three dose finding designs are included in this package: unified phase I design (Ivanova et al. (2009) &lt;<a href="https://doi.org/10.1111%2Fj.1541-0420.2008.01045.x">doi:10.1111/j.1541-0420.2008.01045.x</a>&gt;), Quasi-CRM/Robust-Quasi-CRM (Yuan et al. (2007) &lt;<a href="https://doi.org/10.1111%2Fj.1541-0420.2006.00666.x">doi:10.1111/j.1541-0420.2006.00666.x</a>&gt;, Pan et al. (2014) &lt;<a href="https://doi.org/10.1371%2Fjournal.pone.0098147">doi:10.1371/journal.pone.0098147</a>&gt;) and generalized BOIN design (Mu et al. (2018) &lt;<a href="https://doi.org/10.1111%2Frssc.12263">doi:10.1111/rssc.12263</a>&gt;). The toxicity endpoints can be handled with these functions including equivalent toxicity score (ETS), total toxicity burden (TTB), general continuous toxicity endpoints, with incorporating ordinal grade toxicity information into dose-finding procedure. These functions allow customization of design characteristics to vary sample size, cohort sizes, target dose-limiting toxicity (DLT) rates, discrete or continuous toxicity score, and incorporate safety and/or stopping rules.</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-2">GPL-2</a></td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2022-10-14 22:03:03 UTC; chsu1</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2022-10-15 22:52:37 UTC</td>
</tr>
</table>
<hr>
<h2 id='get_oc_gBOIN_continuous'>
Generate operating characteristics for finding the maximum tolerated dose (MTD) using gBOIN design
</h2><span id='topic+get_oc_gBOIN_continuous'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of the general Bayesian optimal interval (gBOIN) design (Mu et al. 2017) for maximum tolerated dose (MTD)-based dosing-finding trials under the continuous measure
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_gBOIN_continuous(target, c_true, ncohort, cohortsize,
                        n.earlystop = 100, ntrial,
                        mu_1 = 0.6 * target,
                        mu_2 = 1.4 * target,
                        startdose = 1, seed = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_target">target</code></td>
<td>

<p>the continuous target score
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_c_true">c_true</code></td>
<td>

<p>the true mean value of the continuous measure
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_ncohort">ncohort</code></td>
<td>

<p>the number of cohorts
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_cohortsize">cohortsize</code></td>
<td>

<p>the cohort size
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_ntrial">ntrial</code></td>
<td>

<p>the number of simulated trials
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_mu_1">mu_1</code></td>
<td>

<p>the lower bound. The default value is mu_1 = 0.6 * target
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_mu_2">mu_2</code></td>
<td>

<p>the upper bound. The default value is mu_2 = 1.4 * target
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_startdose">startdose</code></td>
<td>

<p>the starting dose level. The default value is startdose = 1
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_continuous_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_gBOIN_continuous()</code> returns the operating characteristics of generalized Bayesian optimal interval design (gBOIN) as a list object, including: (1) selection percentage of each dose, (2) the average number of patients treated at each dose
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 1.47
c_true &lt;- c(0.11, 0.25, 0.94, 1.47, 2.38, 2.40)
ncohort &lt;- 10
cohortsize &lt;- 3
ntrial &lt;- 4000
get_oc_gBOIN_continuous(target = target, c_true = c_true,
                        ncohort = ncohort, cohortsize = cohortsize,
                        ntrial = ntrial)
</code></pre>

<hr>
<h2 id='get_oc_gBOIN_TB'>
Generate operating characteristics for finding the maximum tolerated dose (MTD) defined by Toxicity Burden (TB) Score  using gBOIN design
</h2><span id='topic+get_oc_gBOIN_TB'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of the generalized Bayesian optimal interval (gBOIN) design (Mu et al. 2017) for maximum tolerated dose (MTD) (defined by the toxicity burden (BT) score proposed by Bekele et al. (2004))-based dosing-finding trials using. The algorithm of this function is exactly same to the get_oc_gBOIN_Continuous() just the input parameter is used by the TB score
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_gBOIN_TB(target, pmat, weight, ncohort, cohortsize,
                n.earlystop = 100, ntrial, mu_1 = 0.6 * target,
                mu_2 = 1.4 * target, startdose = 1, seed = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="get_oc_gBOIN_TB_+3A_target">target</code></td>
<td>

<p>the target TB score
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_pmat">pmat</code></td>
<td>

<p>pmat is a list. Each element is a matrix, representing the probability of different toxicity type and scale under
different dose levels.
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_weight">weight</code></td>
<td>

<p>the severity weight
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_ncohort">ncohort</code></td>
<td>

<p>the number of cohort
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_cohortsize">cohortsize</code></td>
<td>

<p>the cohort size
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_ntrial">ntrial</code></td>
<td>

<p>the number of simulated trial
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_mu_1">mu_1</code></td>
<td>

<p>the lower bound. The default value is p.saf = 0.6 * target
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_mu_2">mu_2</code></td>
<td>

<p>the upper bound. The default value is mu_2 = 1.4 * target
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_startdose">startdose</code></td>
<td>

<p>the starting dose level. The default value is startdose = 1
</p>
</td></tr>
<tr><td><code id="get_oc_gBOIN_TB_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_gBOIN_TB()</code> returns the operating characteristics of  generalized Bayesian optimal interval design as a list object, including: (1) selection percentage of each dose, (2) the average number of patients treated at each dose
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Bekele, B. Nebiyou, and Peter F. Thall. &quot;Dose-finding based on multiple toxicities in a soft tissue sarcoma trial.&quot; Journal of the American Statistical Association 99, no. 465 (2004): 26-35.
</p>
<p>Rongji Mu, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, Jun Yin: gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points. Royal Statistical Society 2019
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 3.344
ncohort &lt;- 10
cohortsize &lt;- 3
ntrial &lt;- 1000
rate &lt;- 1.1
weight &lt;- rate * rbind(c(0,1,1.5,5,6), c(0,2.5,6,rep(0,2)), c(0,2,3,6,0),
                       c(0,1.5,2,0,0), c(0,0.5,1,0,0))
pmat &lt;- list()
pmat[[1]] &lt;- rbind(c(0.5,0.5,rep(0,3)),
                   c(1,rep(0,4)),
                   c(1,rep(0,4)),
                   c(1,rep(0,4)),
                   c(0.5,0,0.5,0,0))
pmat[[2]] &lt;- rbind(c(0.5,0,0.5,0,0),
                   c(1,rep(0,4)),
                   c(0.5,0.5,0,0,0),
                   c(0.5,0.5,rep(0,3)),
                   c(0.46,0,0.54,rep(0,2)))
pmat[[3]] &lt;- rbind(c(0.5,0,0.5,0,0),
                   c(0.4,0.6,0,0,0),
                   c(0.25,0.75,0,0,0),
                   c(0.5,0.5,0,0,0),
                   c(1,0,0,0,0))
pmat[[4]] &lt;- rbind(c(0.5,0,0.5,0,0),
                   c(0.4,0.6,0,0,0),
                   c(0.25,0.75,0,0,0),
                   c(0.5,0.5,0,0,0),
                   c(0.5,0,0.5,0,0))
pmat[[5]] &lt;- rbind(c(0.5,0,0.5,0,0),
                   c(0,1,0,0,0),
                   c(0.25,0.75,0,0,0),
                   c(0.5,0.5,0,0,0),
                   c(0.5,0,0.5,0,0))
pmat[[6]] &lt;- rbind(c(0,0.5,0.5,0,0),
                   c(0,1,0,0,0),
                   c(0,1,0,0,0),
                   c(0.5,0.5,0,0,0),
                   c(0.5,0,0.5,0,0))
pmat[[7]] &lt;- rbind(c(0,0.5,0.5,0,0),
                   c(0,1,0,0,0),
                   c(0,1,0,0,0),
                   c(0,0.5,0.5,0,0),
                   c(0.5,0,0.5,0,0))
pmat[[8]] &lt;- rbind(c(0,0.5,0.5,0,0),
                   c(0,1,0,0,0),
                   c(0,0,1,0,0),
                   c(0,0.5,0.5,0,0),
                   c(0.5,0,0.5,0,0))
pmat[[9]] &lt;- rbind(c(0,0,1,0,0),
                   c(0,1,0,0,0),
                   c(0,0,1,0,0),
                   c(0,0,1,0,0),
                   c(0,0,1,0,0))
pmat[[10]] &lt;- rbind(c(0,0,1,0,0),
                    c(0,1,0,0,0),
                    c(1/3,0,0,2/3,0),
                    c(0,0,1,0,0),
                    c(0,0,1,0,0))
get_oc_gBOIN_TB(target = target, pmat = pmat, weight = weight,
                ncohort = ncohort, cohortsize = cohortsize,
                ntrial = ntrial)
</code></pre>

<hr>
<h2 id='get_oc_Ivanova_binary'>
Generate operating characteristics for finding the maximum tolerated dose (MTD) of binary endpoint using design by Ivanova et al (2009)
</h2><span id='topic+get_oc_Ivanova_binary'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of the dose-finding design of binary endpoint by Ivanova et al (2009)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_Ivanova_binary(target, eps = 1, truetox, ncohort, cohortsize,
                      n.earlystop = 100, ntrial, startdose = 1,
                      seed = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="get_oc_Ivanova_binary_+3A_target">target</code></td>
<td>

<p>the target toxicity rate
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_eps">eps</code></td>
<td>

<p>the decision criterion. The default value is eps = 1
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_truetox">truetox</code></td>
<td>

<p>a vector containing the true toxicity probabilities of the investigational dose levels
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_ncohort">ncohort</code></td>
<td>

<p>the number of cohorts
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_cohortsize">cohortsize</code></td>
<td>

<p>the cohort size
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_ntrial">ntrial</code></td>
<td>

<p>the number of trials
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_startdose">startdose</code></td>
<td>

<p>the starting dose level. The default value is startdose = 1
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_binary_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_Ivanova_binary()</code> returns the operating characteristics of Ivanova design as a list object, including: (1) selection percentage at each dose level (2) patients treated at each dose level
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Ivanova, Anastasia, and Se Hee Kim. &quot;Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.&quot; Biometrics 65, no. 1 (2009): 307-315.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.3
truetox &lt;- c(0.30, 0.45, 0.50, 0.55, 0.60, 0.65)
ncohort &lt;- 10
cohortsize &lt;- 3
ntrial &lt;- 4000
get_oc_Ivanova_binary(target = target, truetox = truetox, ncohort = ncohort,
                      cohortsize = cohortsize, ntrial = ntrial)

</code></pre>

<hr>
<h2 id='get_oc_Ivanova_continuous'>
Generate operating characteristics for finding the maximum tolerated dose (MTD) of continuous endpoint using design by Ivanova et al (2009)
</h2><span id='topic+get_oc_Ivanova_continuous'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of the dose-finding design of continuous endpoint by Ivanova et al (2009)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_Ivanova_continuous(target, eps = 1, ptox, ncohort,
                          cohortsize, n.earlystop = 100,
                          ntrial, startdose = 1, seed = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_target">target</code></td>
<td>

<p>the continuous target score
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_eps">eps</code></td>
<td>

<p>the decision criterion. The default value is eps = 1
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_ptox">ptox</code></td>
<td>

<p>the true mean value of the continuous measure
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_ncohort">ncohort</code></td>
<td>

<p>the number of cohorts
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_cohortsize">cohortsize</code></td>
<td>

<p>the cohort size
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_ntrial">ntrial</code></td>
<td>

<p>the number of simulated trials
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_startdose">startdose</code></td>
<td>

<p>the starting dose level. The default value is startdose = 1
</p>
</td></tr>
<tr><td><code id="get_oc_Ivanova_continuous_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_Ivanova_continuous()</code> returns the operating characteristics of Ivanova design as a list object, including: (1) selection percentage at each dose level (2) patients treated at each dose level
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Fang Wang, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Ivanova, Anastasia, and Se Hee Kim. &quot;Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.&quot; Biometrics 65, no. 1 (2009): 307-315.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 1.47
ptox &lt;- c(0.11, 0.25, 0.94, 1.47, 2.38, 2.40)
ncohort &lt;- 10
cohortsize &lt;- 3
ntrial &lt;- 4000
get_oc_Ivanova_continuous(target = target, ptox = ptox, ncohort = ncohort,
                          cohortsize = cohortsize, ntrial = ntrial)

</code></pre>

<hr>
<h2 id='get_oc_QuasiBOIN'>
Generate operating characteristics for finding the maximum tolerated dose (MTD) defined by Equivalent Score (ET) using Quasi-CRM design using gBOIN
</h2><span id='topic+get_oc_QuasiBOIN'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of Quasi-CRM design (Yuan et al. 2007) and Robust-Quasi-CRM design (Pan et al. 2014) for finding the maximum tolerated dose (MTD) using Equivalent Score (ET) derived from toxicity grade information using the gBOIN design (Mu et al. 2017)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_QuasiBOIN(target, p.true, score, ncohort, cohortsize, n.earlystop = 100,
                 startdose = 1, p.saf = 0.6 * target, p.tox = 1.4 * target,
                 cutoff.eli = 0.95, extrasafe = FALSE, offset = 0.05,
                 ntrial = 1000, seed = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="get_oc_QuasiBOIN_+3A_target">target</code></td>
<td>

<p>the target DLT rate
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_p.true">p.true</code></td>
<td>

<p>the true toxicity probability at each dose level
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_score">score</code></td>
<td>

<p>the default value is score = seq(0, 1.5, by = 0.5) / 1.5
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_ncohort">ncohort</code></td>
<td>

<p>the number of cohorts
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_cohortsize">cohortsize</code></td>
<td>

<p>the cohort size
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_startdose">startdose</code></td>
<td>

<p>the starting dose level. The default value is startdose = 1
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_p.saf">p.saf</code></td>
<td>

<p>lower bound. The default value is p.saf = 0.6 * target
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_p.tox">p.tox</code></td>
<td>

<p>upper bound. The default value is p.tox = 1.4 * target
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_cutoff.eli">cutoff.eli</code></td>
<td>

<p>the cutoff to eliminate an overly toxic dose for safety. The default value is cutoff.eli = 0.95
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_extrasafe">extrasafe</code></td>
<td>

<p>extrasafe	set extrasafe = TRUE to impose a more stringent stopping rule. The default value is extrasafe = FALSE
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_offset">offset</code></td>
<td>

<p>when extrasafe = TRUE will have effect. The default value is offset = 0.05
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_ntrial">ntrial</code></td>
<td>

<p>the number of simulated trials
</p>
</td></tr>
<tr><td><code id="get_oc_QuasiBOIN_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_QuasiBOIN()</code> returns the operating characteristics of Bayesian optimal interval design as a list object,
including:
(1) the target DLT rate,
(2) the true DLT rate at different scale for each dose level,
(3) number of cohort,
(4) cohortsize,
(5) starting dose level,
(6) lower bound,
(7) upper bound,
(8) selection percentage of each dose level,
(9) the average number of patients treated at each dose,
(10) the average number of patients responded to toxicity at each dose level
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Yuan, Z., R. Chappell, and H. Bailey. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.&quot; Biometrics 63, no. 1 (2007): 173-179.
</p>
<p>Pan, Haitao, Cailin Zhu, Feng Zhang, Ying Yuan, Shemin Zhang, Wenhong Zhang, Chanjuan Li, Ling Wang, and Jielai Xia. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian model selection approach.&quot; PloS one 9, no. 5 (2014): e98147.
</p>
<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.47 / 1.5
p.true &lt;- matrix(c(0.83, 0.12, 0.04, 0.01,
                   0.75, 0.15, 0.07, 0.03,
                   0.62, 0.18, 0.11, 0.09,
                   0.51, 0.19, 0.14, 0.16,
                   0.34, 0.16, 0.15, 0.35,
                   0.19, 0.11, 0.11, 0.59), ncol = 4, byrow = TRUE)
score &lt;- seq(0, 1.5,by = 0.5) / 1.5
ncohort &lt;- 10
cohortsize &lt;- 3
ntrial &lt;- 4000
get_oc_QuasiBOIN(target = target, p.true = p.true, score = score, ncohort = ncohort,
                 cohortsize = cohortsize, ntrial = ntrial)

</code></pre>

<hr>
<h2 id='get_oc_RQ_CRM'>
Generate operating characteristics for finding the maximum tolerated dose (MTD) defined by Equivalent Score (ET) using Quasi-CRM design
</h2><span id='topic+get_oc_RQ_CRM'></span>

<h3>Description</h3>

<p>Obtain the operating characteristics of Quasi-CRM design (Yuan et al. 2007) and Robust-Quasi-CRM design (Pan et al. 2014) for finding the maximum tolerated dose (MTD) using Equivalent Score (ET) derived from toxicity grade information
</p>


<h3>Usage</h3>

<pre><code class='language-R'>get_oc_RQ_CRM(ptox, skeletons, target, score, cohortsize,
              ncohort, n.earlystop = 100, start.dose = 1,
              mselection = 1, cutoff.eli = 0.90, ntrial = 10,
              seed = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="get_oc_RQ_CRM_+3A_ptox">ptox</code></td>
<td>

<p>true toxicity probability at each dose level
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_skeletons">skeletons</code></td>
<td>

<p>a matrix to provide multiple skeletons with each row presenting a skeleton. If just one row, the function implements the Quasi-CRM design; if &gt;=2 rows, the function implements the Robust-Quasi-CRM designn
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_target">target</code></td>
<td>

<p>the target toxicity score
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_score">score</code></td>
<td>

<p>the vector weight for ordinal toxicity levels
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_cohortsize">cohortsize</code></td>
<td>

<p>the cohort size
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_ncohort">ncohort</code></td>
<td>

<p>the number of cohort
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_start.dose">start.dose</code></td>
<td>

<p>the starting dose level. The default value is start.dose = 1
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_mselection">mselection</code></td>
<td>

<p>mselection = 1 (or 0) indicate to use Bayesian model selection (or mode averaging) to make inference across multiple skeletons. The default value is mselection = 1. It only applies to the Robust-Quasi-CRM design
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_cutoff.eli">cutoff.eli</code></td>
<td>

<p>the cutoff to eliminate an overly toxic dose for safety. The default value is cutoff.eli = 0.90
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_ntrial">ntrial</code></td>
<td>

<p>the number of simulated trials. The default value is ntrial = 10
</p>
</td></tr>
<tr><td><code id="get_oc_RQ_CRM_+3A_seed">seed</code></td>
<td>

<p>the seed. The default value is seed = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>get_oc_RQ_CRM()</code> returns the operating characteristics of (Robust)-Quasi-CRM design as a list object, including: (1) selection percentage at each dose level (2) patients treated at each dose level
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Yuan, Z., R. Chappell, and H. Bailey. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.&quot; Biometrics 63, no. 1 (2007): 173-179.
</p>
<p>Pan, Haitao, Cailin Zhu, Feng Zhang, Ying Yuan, Shemin Zhang, Wenhong Zhang, Chanjuan Li, Ling Wang, and Jielai Xia. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian model selection approach.&quot; PloS one 9, no. 5 (2014): e98147.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>### Scenario 1 in Yuan et al. (2007) and Pan et al. (2014)
target &lt;- 0.47
score &lt;- c(0, 0.5, 1, 1.5)
cohortsize &lt;- 3
ncohort &lt;- 10
ntrial &lt;- 10

ptox &lt;- matrix(nrow = 4, ncol = 6)
ptox[1,] &lt;- c(0.83, 0.75, 0.62, 0.51, 0.34, 0.19)
ptox[2,] &lt;- c(0.12, 0.15, 0.18, 0.19, 0.16, 0.11)
ptox[3,] &lt;- c(0.04, 0.07, 0.11, 0.14, 0.15, 0.11)
ptox[4,] &lt;- c(0.01, 0.03, 0.09, 0.16, 0.35, 0.59)


### specify one skeleton (Quasi-CRM design)
p1 &lt;- c(0.11, 0.25, 0.40, 0.55, 0.75, 0.85)

get_oc_RQ_CRM(ptox = ptox, skeletons = p1, target = target,
              score = score, cohortsize = cohortsize,
              ncohort = ncohort, ntrial = ntrial)




###########################################

### specify three skeletons (Quasi-CRM design)
p1 &lt;- c(0.11, 0.25, 0.40, 0.55, 0.75, 0.85)
p2 &lt;- c(0.05, 0.10, 0.15, 0.25, 0.40, 0.65)
p3 &lt;- c(0.20, 0.40, 0.60, 0.75, 0.85, 0.95)
skeletons &lt;- rbind(p1, p2, p3)


get_oc_RQ_CRM(ptox = ptox, skeletons = skeletons, target = target,
              score = score, cohortsize = cohortsize,
              ncohort = ncohort, ntrial = ntrial)


</code></pre>

<hr>
<h2 id='next_gBOIN_continuous'>
Determine the dose for the next cohort of new patients for single-agent trials that aim to find a maximum tolerated dose (MTD) using gBOIN design
</h2><span id='topic+next_gBOIN_continuous'></span>

<h3>Description</h3>

<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find a MTD under continuous measure using gBOIN design (Mu et al., 2017)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>next_gBOIN_continuous(target, n, y, d, mu_1 = 0.6 * target, mu_2 = 1.4 * target)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="next_gBOIN_continuous_+3A_target">target</code></td>
<td>

<p>the continuous target score
</p>
</td></tr>
<tr><td><code id="next_gBOIN_continuous_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="next_gBOIN_continuous_+3A_y">y</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
<tr><td><code id="next_gBOIN_continuous_+3A_d">d</code></td>
<td>

<p>the current dose level
</p>
</td></tr>
<tr><td><code id="next_gBOIN_continuous_+3A_mu_1">mu_1</code></td>
<td>

<p>the lower bound. The default value is 0.6 * target
</p>
</td></tr>
<tr><td><code id="next_gBOIN_continuous_+3A_mu_2">mu_2</code></td>
<td>

<p>the upper bound. The default value is 1.4 * target
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>next_gBOIN_continuous()</code> returns recommended dose level for the next cohort as a numeric value under continuous measure
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 1.47
n &lt;- c(3, 3, 3, 9, 0, 0)
y &lt;- c(0.1951265, 1.5434317, 2.1967343, 13.9266838, 0, 0)
d &lt;- 4
next_gBOIN_continuous(target = target, n = n, y = y, d = d)
</code></pre>

<hr>
<h2 id='next_gBOIN_TB'>
Determine the dose for the next cohort of new patients for single-agent trials that aim to find a maximum tolerated dose (MTD) defined by Toxicity Burden (TB) Score  using gBOIN design
</h2><span id='topic+next_gBOIN_TB'></span>

<h3>Description</h3>

<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find the MTD defined by the toxicity burden (BT) score proposed by Bekele et al. (2004) using the generalized Bayesian optimal interval (gBOIN) design (Mu et al. 2017) . The algorithm of this function is exactly same to the next_mtd_gBOIN_Continuous() just the input parameter is used by the TB score
</p>


<h3>Usage</h3>

<pre><code class='language-R'>next_gBOIN_TB(target, n, y, d, mu_1 = 0.6 * target, mu_2 = 1.4 * target)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="next_gBOIN_TB_+3A_target">target</code></td>
<td>

<p>the target TB score
</p>
</td></tr>
<tr><td><code id="next_gBOIN_TB_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="next_gBOIN_TB_+3A_y">y</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
<tr><td><code id="next_gBOIN_TB_+3A_d">d</code></td>
<td>

<p>the current dose level
</p>
</td></tr>
<tr><td><code id="next_gBOIN_TB_+3A_mu_1">mu_1</code></td>
<td>

<p>the lower bound. The default value is 0.6 * target
</p>
</td></tr>
<tr><td><code id="next_gBOIN_TB_+3A_mu_2">mu_2</code></td>
<td>

<p>the upper bound. The default value is 1.4 * target
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>next_gBOIN_TB()</code> returns recommended dose level for the next cohort as a numeric value under ordinal measure
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>B. Nebiyou Bekele &amp; Peter F Thall (2004) Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial, Journal of the American Statistical Association
</p>
<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 3.344
n &lt;- c(3, 9, 6, 0, 0, 0, 0, 0, 0, 0)
y &lt;- c(5.5, 26.95, 25.3, 0, 0, 0, 0, 0, 0, 0)
d &lt;- 2
next_gBOIN_TB(target = target, n = n, y = y, d = d)
</code></pre>

<hr>
<h2 id='next_Ivanova_binary'>
Determine the dose for the next cohort of new patients of binary endpoint using design by Ivanova et al (2009)
</h2><span id='topic+next_Ivanova_binary'></span>

<h3>Description</h3>

<p>Determine the dose for the next cohort of new patients for single-agent trials of binary endpoint that aim to find a MTD using design by Ivanova et al (2009)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>next_Ivanova_binary(target, eps, y, n, d)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="next_Ivanova_binary_+3A_target">target</code></td>
<td>

<p>the target toxicity rate
</p>
</td></tr>
<tr><td><code id="next_Ivanova_binary_+3A_eps">eps</code></td>
<td>

<p>the decision criterion
</p>
</td></tr>
<tr><td><code id="next_Ivanova_binary_+3A_y">y</code></td>
<td>

<p>the number of toxicity patients at each dose level
</p>
</td></tr>
<tr><td><code id="next_Ivanova_binary_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="next_Ivanova_binary_+3A_d">d</code></td>
<td>

<p>the current dose level
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>next_Ivanova_binary()</code> returns recommended dose level for the next cohort as a numeric value
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Ivanova, Anastasia, and Se Hee Kim. &quot;Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.&quot; Biometrics 65, no. 1 (2009): 307-315.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.3
eps &lt;- 1
y &lt;- c(0, 4, 0, 0, 0, 0)
n &lt;- c(3, 15, 0, 0, 0, 0)
d &lt;- 2
next_Ivanova_binary(target = target, eps = eps, y = y, n = n, d = d)

</code></pre>

<hr>
<h2 id='next_Ivanova_continuous'>
Determine the dose for the next cohort of new patients using Inanova design
</h2><span id='topic+next_Ivanova_continuous'></span>

<h3>Description</h3>

<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find a MTD
</p>


<h3>Usage</h3>

<pre><code class='language-R'>next_Ivanova_continuous(target, eps, c_resp, n, d)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="next_Ivanova_continuous_+3A_target">target</code></td>
<td>

<p>the target toxicity score
</p>
</td></tr>
<tr><td><code id="next_Ivanova_continuous_+3A_eps">eps</code></td>
<td>

<p>the decision criterion
</p>
</td></tr>
<tr><td><code id="next_Ivanova_continuous_+3A_c_resp">c_resp</code></td>
<td>

<p>the list object. Each element contains continuous value for each measurement at the certain dose level
</p>
</td></tr>
<tr><td><code id="next_Ivanova_continuous_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="next_Ivanova_continuous_+3A_d">d</code></td>
<td>

<p>the current dose level
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>next_Ivanova_continuous()</code> returns recommended dose level for the next cohort as a numeric value
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Ivanova, Anastasia, and Se Hee Kim. &quot;Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.&quot; Biometrics 65, no. 1 (2009): 307-315.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 1.47
eps &lt;- 1
c_resp &lt;- list(c(0, 0.05475884, 0.12446843, 0.10131912),
               c(0, 0.4716962, 0.2792428, 0.3296575),
               c(0, 0.3931168, 1.6116607, 0.1642561),
               c(0, 0.9410027, 1.6021326, 1.6115235,
                 1.1735981, 2.5575655, 1.6513679, 1.4269044,
                 0.8983843, 2.2209587),
               0,
               0)
n &lt;- c(3, 3, 3, 9, 0, 0)
d &lt;- 4
next_Ivanova_continuous(target = target, eps = eps, c_resp = c_resp,
                        n = n, d = d)
</code></pre>

<hr>
<h2 id='next_QuasiBOIN'>
Determine the dose for the next cohort of new patients based on equivalent score (ET)-defined target using gBOIN design
</h2><span id='topic+next_QuasiBOIN'></span>

<h3>Description</h3>

<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find a MTD defined by the Equivalent Score (ET) in Quasi-CRM design (Yuan et al. 2007) and Robust-Quasi-CRM design (Pan et al. 2014) using the gBOIN design (Mu et al. 2017)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>next_QuasiBOIN(target, n, y, d, p.saf = 0.6 * target, p.tox = 1.4 * target,
               cutoff.eli = 0.95, extrasafe = FALSE, n.earlystop = 100)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="next_QuasiBOIN_+3A_target">target</code></td>
<td>

<p>the target DLT rate
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_y">y</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_d">d</code></td>
<td>

<p>the current dose level
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_p.saf">p.saf</code></td>
<td>

<p>the lower bound. The default value is p.saf = 0.6 * target
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_p.tox">p.tox</code></td>
<td>

<p>the upper bound. The default value is p.tox = 1.4 * target
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_cutoff.eli">cutoff.eli</code></td>
<td>

<p>the cutoff to eliminate an overly toxic dose for safety. The default value is cutoff.eli = 0.95
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_extrasafe">extrasafe</code></td>
<td>

<p>extrasafe	set extrasafe = TRUE to impose a more stringent stopping . The default value is extrasafe = FALSE
</p>
</td></tr>
<tr><td><code id="next_QuasiBOIN_+3A_n.earlystop">n.earlystop</code></td>
<td>

<p>the early stopping parameter. The default value is n.earlystop = 100
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>next_QuasiBOIN()</code> returns recommended dose level for the next cohort as a numeric value under quasi-binary measure
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Yuan, Z., R. Chappell, and H. Bailey. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.&quot; Biometrics 63, no. 1 (2007): 173-179.
</p>
<p>Pan, Haitao, Cailin Zhu, Feng Zhang, Ying Yuan, Shemin Zhang, Wenhong Zhang, Chanjuan Li, Ling Wang, and Jielai Xia. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian model selection approach.&quot; PloS one 9, no. 5 (2014): e98147.
</p>
<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.47 / 1.5
n &lt;- c(3, 3, 6, 3, 3, 0)
y &lt;- c(0, 0, 1.333333, 0, 1, 0)
d &lt;- 5
next_QuasiBOIN(target = target, n = n, y = y, d = d)

</code></pre>

<hr>
<h2 id='next_RQ_CRM'>
Determine the dose for the next cohort of new patients using Quasi-CRM design
</h2><span id='topic+next_RQ_CRM'></span>

<h3>Description</h3>

<p>Determine the dose for the next cohort of new patients for single-agent trials that aim to find a MTD defined by the Equivalent Score (ET) using Quasi-CRM design (Yuan et al. 2007) and Robust-Quasi-CRM design (Pan et al. 2014)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>next_RQ_CRM(target, n, y, dose.curr, score, skeleton,
            cutoff.eli = 0.90, mselection = 1)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="next_RQ_CRM_+3A_target">target</code></td>
<td>

<p>the target toxicity score
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_n">n</code></td>
<td>

<p>the number of patients treated at each dose level
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_y">y</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_dose.curr">dose.curr</code></td>
<td>

<p>the current dose level
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_score">score</code></td>
<td>

<p>the vector weight for ordinal toxicity levels
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_skeleton">skeleton</code></td>
<td>

<p>a matrix to provide multiple skeletons with each row presenting a skeleton
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_cutoff.eli">cutoff.eli</code></td>
<td>

<p>the cutoff to eliminate an overly toxic dose for safety. The default value is cutoff.eli = 0.90
</p>
</td></tr>
<tr><td><code id="next_RQ_CRM_+3A_mselection">mselection</code></td>
<td>

<p>mselection = 1 (or 0) indicate to use Bayesian model selection (or mode averaging) to make inference across multiple skeletons. The default value is mselection = 1
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>next_RQ_CRM()</code> returns recommended dose level for the next cohort as a numeric value
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Yuan, Z., R. Chappell, and H. Bailey. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.&quot; Biometrics 63, no. 1 (2007): 173-179.
</p>
<p>Pan, Haitao, Cailin Zhu, Feng Zhang, Ying Yuan, Shemin Zhang, Wenhong Zhang, Chanjuan Li, Ling Wang, and Jielai Xia. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian model selection approach.&quot; PloS one 9, no. 5 (2014): e98147.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>### Implement Robust-Quasi-CRM design (Pan et al. 2014) with pre-specifying 3 skeletons
target &lt;- 0.47
score &lt;- c(0, 0.5, 1, 1.5)
p1 &lt;- c(0.11, 0.25, 0.40, 0.55, 0.75, 0.85)
p2 &lt;- c(0.05, 0.10, 0.15, 0.25, 0.40, 0.65)
p3 &lt;- c(0.20, 0.40, 0.60, 0.75, 0.85, 0.95)
skeletons &lt;- rbind(p1, p2, p3)
n &lt;- c(3, 3, 3, 9, 3, 0)
y &lt;- c(0, 0, 1, 1.333333, 3, 0)

## Example to get the ET score 1 on dose 3
## Assume three patients their corresponding score on the dose 3 is
## 0.5, 0.5 and 0.5. Then we calculate ET score as this:
## (0.5 + 0.5 + 0.5) / 1.5 = 1

## Example to get the ET score 1.333333 on dose 4
## Assume nine patients their corresponding score on the dose 4 is
## 0, 0, 0, 0, 0, 0, 0.5, 0.5 and 1. Then we calculate ET score as this:
## (0 + 0 + 0 + 0 + 0 + 0 + 0.5 + 0.5 + 1) / 1.5 = 1.333333

next_RQ_CRM(target = target, n = n, y = y, dose.curr = 5,
            score = score, skeleton = skeletons)

### Implement Quasi-CRM design (Yuan et al. 2007) with pre-specifying/using 1 skeletons
next_RQ_CRM(target = target, n = n, y = y, dose.curr = 5,
            score = score, skeleton = p1)

</code></pre>

<hr>
<h2 id='select_mtd_gBOIN_continuous'>
Select the maximum tolerated dose (MTD) for single agent trials using gBOIN design
</h2><span id='topic+select_mtd_gBOIN_continuous'></span>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) when the trial is completed using gBOIN design (Mu et al. 2017)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>select_mtd_gBOIN_continuous(target, npts, ntox)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="select_mtd_gBOIN_continuous_+3A_target">target</code></td>
<td>

<p>the continuous target score
</p>
</td></tr>
<tr><td><code id="select_mtd_gBOIN_continuous_+3A_npts">npts</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_gBOIN_continuous_+3A_ntox">ntox</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>select_mtd_gBOIN_continuous()</code> returns the selected dose
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Rongji Mu, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, Jun Yin: gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points. Royal Statistical Society 2019
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 1.47
n &lt;- c(3, 3, 3, 9, 0, 0)
y &lt;- c(0.1951265, 1.5434317, 2.1967343, 13.9266838, 0, 0)
select_mtd_gBOIN_continuous(target = target, npts = n, ntox = y)
</code></pre>

<hr>
<h2 id='select_mtd_gBOIN_TB'>
Select the maximum tolerated dose (MTD) defined by Toxicity Burden (TB) Score for single agent trials using gBOIN design
</h2><span id='topic+select_mtd_gBOIN_TB'></span>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) defined by the toxicity burden (BT) score proposed by Bekele et al. (2004) when the trial is completed using the generalized Bayesian optimal interval (gBOIN) design (Mu et al. 2017). The algorithm of this function is exactly same to the Select_mtd_gBOIN.Continuous() just the input parameter is used by the TB score
</p>


<h3>Usage</h3>

<pre><code class='language-R'>select_mtd_gBOIN_TB(target, npts, ntox)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="select_mtd_gBOIN_TB_+3A_target">target</code></td>
<td>

<p>the continuous target score
</p>
</td></tr>
<tr><td><code id="select_mtd_gBOIN_TB_+3A_npts">npts</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_gBOIN_TB_+3A_ntox">ntox</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>select_mtd_gBOIN_TB()</code> returns the selected dose
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>B. Nebiyou Bekele &amp; Peter F Thall (2004) Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial, Journal of the American Statistical Association
</p>
<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 3.344
n &lt;- c(3, 9, 6, 0, 0, 0, 0, 0, 0, 0)
y &lt;- c(5.5, 26.95, 25.3, 0, 0, 0, 0, 0, 0, 0)
select_mtd_gBOIN_TB(target = target, npts = n, ntox = y)
</code></pre>

<hr>
<h2 id='select_mtd_Ivanova_binary'>
Select the maximum tolerated dose (MTD) of binary endpoint for single agent trials using design by Ivanova et al (2009)
</h2><span id='topic+select_mtd_Ivanova_binary'></span>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) when the trial is completed for binary endpoint using design by Ivanova et al (2009)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>select_mtd_Ivanova_binary(target, y, n)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="select_mtd_Ivanova_binary_+3A_target">target</code></td>
<td>

<p>the target toxicity rate
</p>
</td></tr>
<tr><td><code id="select_mtd_Ivanova_binary_+3A_y">y</code></td>
<td>

<p>the number of toxicity patients at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_Ivanova_binary_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>select_mtd_Ivanova_binary()</code> returns a list object including: (1) dose selected (2) patients treated at each dose level
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Ivanova, Anastasia, and Se Hee Kim. &quot;Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.&quot; Biometrics 65, no. 1 (2009): 307-315.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.3
y &lt;- c(0, 4, 0, 0, 0, 0)
n &lt;- c(3, 15, 0, 0, 0, 0)
select_mtd_Ivanova_binary(target = target, y = y, n = n)

</code></pre>

<hr>
<h2 id='select_mtd_Ivanova_continuous'>
Select the maximum tolerated dose (MTD) for single agent trials of continuous endpoint using design by Ivanova et al (2009)
</h2><span id='topic+select_mtd_Ivanova_continuous'></span>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) when the trial is completed for continuous endpoint using design by Ivanova et al (2009)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>select_mtd_Ivanova_continuous(target, c_resp, n)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="select_mtd_Ivanova_continuous_+3A_target">target</code></td>
<td>

<p>the target toxicity score
</p>
</td></tr>
<tr><td><code id="select_mtd_Ivanova_continuous_+3A_c_resp">c_resp</code></td>
<td>

<p>list object. Each element contains continuous value for each measurement
</p>
</td></tr>
<tr><td><code id="select_mtd_Ivanova_continuous_+3A_n">n</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>select_mtd_Ivanova_continuous()</code> returns a list object including: (1) dose selected (2) patients treated at each dose level
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Ivanova, Anastasia, and Se Hee Kim. &quot;Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.&quot; Biometrics 65, no. 1 (2009): 307-315.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 1.47
c_resp &lt;- list(c(0, 0.05475884, 0.12446843, 0.10131912),
               c(0, 0.4716962, 0.2792428, 0.3296575),
               c(0, 0.3931168, 1.6116607, 0.1642561),
               c(0, 0.9410027, 1.6021326, 1.6115235,
                 1.1735981, 2.5575655, 1.6513679, 1.4269044,
                 0.8983843, 2.2209587),
               0,
               0)
n &lt;- c(3, 3, 3, 9, 0, 0)
select_mtd_Ivanova_continuous(target = target, c_resp = c_resp, n = n)
</code></pre>

<hr>
<h2 id='select_mtd_QuasiBOIN'>
Select the maximum tolerated dose (MTD)-defined by equivalent score (ET) using gBOIN design
</h2><span id='topic+select_mtd_QuasiBOIN'></span>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) defined by the Equivalent Score (ET) in Quasi-CRM design (Yuan et al. 2007) and Robust-Quasi-CRM design (Pan et al. 2014) when the trial is completed using the gBOIN design (Mu et al. 2017)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>select_mtd_QuasiBOIN(target, npts, ntox, cutoff.eli = 0.95, extrasafe = FALSE,
                     offset = 0.05, print = FALSE)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_target">target</code></td>
<td>

<p>the target DLT rate
</p>
</td></tr>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_npts">npts</code></td>
<td>

<p>the number of patients enrolled at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_ntox">ntox</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_cutoff.eli">cutoff.eli</code></td>
<td>

<p>the cutoff to eliminate an overly toxic dose for safety. The default value is cutoff.eli = 0.95
</p>
</td></tr>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_extrasafe">extrasafe</code></td>
<td>

<p>extrasafe	set extrasafe = TRUE to impose a more stringent stopping rule. The default value is extrasafe = FALSE
</p>
</td></tr>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_offset">offset</code></td>
<td>

<p>when extrasafe = TRUE will have effect. The default value is offset = 0.05
</p>
</td></tr>
<tr><td><code id="select_mtd_QuasiBOIN_+3A_print">print</code></td>
<td>

<p>print the additional result or not. The default value is print = FALSE
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>select_mtd_QuasiBOIN()</code> returns the selected dose
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Yuan, Z., R. Chappell, and H. Bailey. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.&quot; Biometrics 63, no. 1 (2007): 173-179.
</p>
<p>Pan, Haitao, Cailin Zhu, Feng Zhang, Ying Yuan, Shemin Zhang, Wenhong Zhang, Chanjuan Li, Ling Wang, and Jielai Xia. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian model selection approach.&quot; PloS one 9, no. 5 (2014): e98147.
</p>
<p>Mu, Rongji, Ying Yuan, Jin Xu, Sumithra J. Mandrekar, and Jun Yin. &quot;gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.&quot; Journal of the Royal Statistical Society. Series C: Applied Statistics 68, no. 2 (2019): 289-308.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.47 / 1.5
n &lt;- c(3, 3, 6, 9, 9, 0)
y &lt;- c(0, 0, 1.333333, 2.333333, 3.666667, 0)
select_mtd_QuasiBOIN(target = target, npts = n, ntox = y)
</code></pre>

<hr>
<h2 id='select_mtd_RQ_CRM'>
Select the maximum tolerated dose (MTD) using Quasi-CRM design
</h2><span id='topic+select_mtd_RQ_CRM'></span>

<h3>Description</h3>

<p>Select the maximum tolerated dose (MTD) defined by the Equivalent Score (ET) when the trial is completed using Quasi-CRM design (Yuan et al. 2007) and Robust-Quasi-CRM design (Pan et al. 2014)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>select_mtd_RQ_CRM(target, n, y, score, skeleton, mselection = 1)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="select_mtd_RQ_CRM_+3A_target">target</code></td>
<td>

<p>the target toxicity score
</p>
</td></tr>
<tr><td><code id="select_mtd_RQ_CRM_+3A_n">n</code></td>
<td>

<p>the number of patients treated at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_RQ_CRM_+3A_y">y</code></td>
<td>

<p>the toxicity score at each dose level
</p>
</td></tr>
<tr><td><code id="select_mtd_RQ_CRM_+3A_score">score</code></td>
<td>

<p>the vector weight for ordinal toxicity levels
</p>
</td></tr>
<tr><td><code id="select_mtd_RQ_CRM_+3A_skeleton">skeleton</code></td>
<td>

<p>a matrix to provide multiple skeletons with each row presenting a skeleton
</p>
</td></tr>
<tr><td><code id="select_mtd_RQ_CRM_+3A_mselection">mselection</code></td>
<td>

<p>mselection = 1 (or 0) indicate to use Bayesian model selection (or mode averaging) to make inference across multiple skeletons. The default value is mselection = 1
</p>
</td></tr>
</table>


<h3>Value</h3>

<p><code>select_mtd_RQ_CRM()</code> returns a vector to indicate which dose is selected
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Haitao Pan, Rongji Mu
</p>


<h3>References</h3>

<p>Yuan, Z., R. Chappell, and H. Bailey. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.&quot; Biometrics 63, no. 1 (2007): 173-179.
</p>
<p>Pan, Haitao, Cailin Zhu, Feng Zhang, Ying Yuan, Shemin Zhang, Wenhong Zhang, Chanjuan Li, Ling Wang, and Jielai Xia. &quot;The continual reassessment method for multiple toxicity grades: a Bayesian model selection approach.&quot; PloS one 9, no. 5 (2014): e98147.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>target &lt;- 0.47
score &lt;- c(0, 0.5, 1, 1.5)
p1 &lt;- c(0.11, 0.25, 0.40, 0.55, 0.75, 0.85)
p2 &lt;- c(0.05, 0.10, 0.15, 0.25, 0.40, 0.65)
p3 &lt;- c(0.20, 0.40, 0.60, 0.75, 0.85, 0.95)
skeletons &lt;- rbind(p1, p2, p3)
n &lt;- c(3, 3, 3, 9, 3, 0)
y &lt;- c(0, 0, 1, 1.333333, 3, 0)

## Example to get the ET score 1 on dose 3
## Assume three patients their corresponding score on the dose 3 is
## 0.5, 0.5 and 0.5. Then we calculate ET score as this:
## (0.5 + 0.5 + 0.5) / 1.5 = 1

## Example to get the ET score 1.333333 on dose 4
## Assume nine patients their corresponding score on the dose 4 is
## 0, 0, 0, 0, 0, 0, 0.5, 0.5 and 1. Then we calculate ET score as this:
## (0 + 0 + 0 + 0 + 0 + 0 + 0.5 + 0.5 + 1) / 1.5 = 1.333333

select_mtd_RQ_CRM(target = target, n = n, y = y, score = score,
                  skeleton = skeletons)
</code></pre>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
